glp-1 for addiction treatment The Role of in Curbing Addiction: Uses and Potential GLP-1 Alcohol Cravings: How Ozempic

Pay the $50 monthly copay

Das SR, Everett BM, Birtcher KK, Brown JM, Januzzi JL, Kalyani RR, et al

continued treatment helps maintain losses Common side effects that may affect treatment adherence include: Nausea and vomiting (usually temporary, improving after several weeks) Diarrhoea or constipation Abdominal discomfort Fatigue Injection site reactions Important safety considerations include: Risk of hypoglycaemia if used with insulin or sulfonylureas [4] Do not stop or reduce insulin rapidly without medical advice (risk of diabetic ketoacidosis) [4] Maintain adequate hydration to prevent acute kidney injury [4] Potential for gallbladder problems (pain, stones) Rare risk of intestinal obstruction Possible worsening of diabetic retinopathy in people with diabetes during rapid improvement in blood glucose For tirzepatide: use additional non-oral contraception for 4 weeks after initiation and each dose escalation Patients should contact their GP if they experience: persistent vomiting preventing fluid intake, severe abdominal pain, signs of gallbladder disease, or unusual thyroid symptoms

Clinical Kidney Journal

Adverse drug reactions of GLP-1 agonists: A systematic review of case reports

Insulin therapy has been shown to reduce hepatic steatosis and improve liver enzyme levels, though its impact on fibrosis is not well documented